Breast cancer patient delay in Fukushima, Japan following the 2011 triple disaster: a long-term retrospective study

Akihiko Ozaki(Jyoban Hospital of Tokiwa Foundation), Hiromichi Ohira(Osaka Medical Center for Cancer and Cardiovascular Diseases), Shigeaki Kato(Fukushima Medical University), Sae Ochi(Soma Central Hospital), Claire Leppold(Imakiire General Hospital), Tsuyoshi Nemoto, Tetsuya Tanimoto(Kawasaki Medical School), Shigehira Saji(Fukushima Medical University), Masahiro Kami(Medical Governance Research Institute), Takeru Yokota, Yukio Kanazawa(Imakiire General Hospital), Shuhei Nomura(Keio University), Masaharu Tsubokura(Fukushima Medical University), Tomohiro Morita(Soma Central Hospital), Toyoaki Sawano(Jyoban Hospital of Tokiwa Foundation), Manabu Tsukada
BMC Cancer
June 19, 2017
10.1186/s12885-017-3412-4
Cited by 64

Related Papers

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
|The Lancet|2020|1.1k
RETRACTED ARTICLE: Purification and Identification of p68 RNA Helicase Acting as a Transcriptional Coactivator Specific for the Activation Function 1 of Human Estrogen Receptor α
|Molecular and Cellular Biology|1999|358
Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis
|The Lancet|2022|319
STAT6 Inhibits TGF-β1-mediated Foxp3 Induction through Direct Binding to the Foxp3 Promoter, Which Is Reverted by Retinoic Acid Receptor
|Journal of Biological Chemistry|2008|149
A Novel Isoform of Rat Estrogen Receptor Beta with 18 Amino Acid Insertion in the Ligand Binding Domain as a Putative Dominant Negative Regulator of Estrogen Action
|Biochemical and Biophysical Research Communications|1998|135